Top Markets
Coin of the day
Allena Pharmaceuticals, Inc. Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc.

ALNAQ
Rankning i aktier #42825
Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on... Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on unearthing, developing, and marketing oral enzyme therapies. These treatments are devised to assist patients in the United States afflicted by uncommon and serious metabolic as well as renal conditions. Central to its pipeline is ALLN-346, an innovative enzyme designed to degrade urate, targeting hyperuricemia and gout in individuals with advanced chronic kidney disease. The company, which commenced operations in 2011 and has its main office in Newton, Massachusetts, made headlines on September 2, 2022, by seeking voluntary reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Aktiekurs
$0.000001
Senast synkroniserad: 2023-12-13
Marknadsvärde
$23.51
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Allena Pharmaceuticals, Inc. (ALNAQ)

Kategori

Historik för aktiesplit för Allena Pharmaceuticals, Inc. (ALNAQ)
Aktien Allena Pharmaceuticals, Inc. (symbol: ALNAQ) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 12, 2026.
En ALNAQ-aktie köpt före Aug 12, 2026 motsvarar nu 0 ALNAQ-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR